- Products & services
The MHRA have recently issued a statement outlining the expectations regarding unlicensed orders from Specials manufacturers. The article confirms that to meet regulations all Specials orders must be submitted in writing to protect patient safety. Here at Quantum Pharmaceutical we want to ensure that all of our customers stay up to date with MHRA guidelines and that you continue to remain compliant with minimal impact to your day to day operation.
The Specials Tariffs for England and Wales, and also Scotland have been updated, effective from 1st Aug 2017. We have incorporated price and line updates into our processes to ensure all customer paperwork and endorsing information are accurate. Read on for a summary of the changes.
At Quantum Pharmaceutical we put quality at the centre of all our processes to ensure high-calibre medication is prepared for our customers. Dave Sanson, Group Quality Director for the Quantum Pharma Group, provides further insights into the business‘ procedures and why we take quality so seriously.
With pharmacies playing an integral role in driving patient safety, we put a spotlight on the responsibilities pertinent to pharmacy staff to ensure unlicensed medicines are obtained efficiently and safely. In our guide, we focus on how to protect patients‘ safety through quality standards and the documentation that should be supplied with every unlicensed medicine.
The media has put a spotlight on the Healthcare sector and its challenge to drive patient care and safety. With this at the forefront of the industry‘s mind, we asked our pharmacy customers what aspects of our service have helped them drive patient safety in these challenging times.
The Specials Tariffs for England and Wales, and also Scotland have been updated, effective from 1st February 2017. We have incorporated price and line updates into our processes to ensure all customer paperwork and endorsing information are accurate. Read on for a summary of the changes.
When it comes to ordering unlicensed medication, it‘s critical to the patient that the medication supplied meets their specific needs. The Royal Pharmaceutical Society (RPS) updated its guidance earlier this year and to ensure we and our customers adhere to the guidelines, when ordering an unlicensed product, our customer service team will always confirm the order taken to minimise the risk of errors.
For patients who are on narrow therapeutic index medications, guidance advises that they are maintained on the same brand of medication to manage their condition and support positive clinical outcomes. Acting in response to the MHRA advice, we have implemented a series of safeguarding prompts, which trigger at the point of order for specific medications.
The Specials Tariff for England and Wales, and also Scotland, have been updated effective from 1st November 2016. We have incorporated price and line updates into our processes to ensure all customer paperwork and endorsing information are accurate. View a summary of the tariff changes.
The Birmingham NEC once again played host to the Pharmacy Show on the 25 and 26 September where, exhibiting as part of the parent company, Quantum Pharma, our experts had the opportunity to make new contacts and showcase our innovative solutions for busy pharmacies. We also invited our valued customers to the VIP Lounge where they could enjoy networking with like-minded peers over a cup of coffee and learn more about the Group’s offerings.
The Specials Tariff for England and Wales, and also Scotland, have been updated effective from 1st August 2016. We have incorporated price and line updates into our processes to ensure all customer paperwork and endorsing information are accurate. View a summary of the tariff changes.
Following the Brexit decision, Catherine Brown, Commercial Director offers comfort and reassurance that our service remains unchanged as we continue to focus all efforts on delivering an innovative service that meets the needs of our customers and your patients.
Whatever the future holds for trade policies with the EU, the inward and outward flow of products between the Single Market means that we can't fully detach ourselves from their guidelines. This could be the case for the Falsified Medicines Directive (FMD), which is due to come into force on 9 February 2019. While the future unfolds, we look at some key considerations as they stand to help you plan for the potential changes.
The Specials Tariffs for England and Wales as well as for Scotland have been updated, effective from 1st May 2016. We have incorporated price and line updates into our processes to ensure all customer paperwork and endorsing information are accurate. View a summary of the tariff changes.
In a bid to help you meet patient needs, quickly and efficiently, you can count on us to work through the toughest challenges and the shortest timescales to find thousands of hard-to-source specials and obtains with a single call, email or fax. We speak to Sourcing expert, Stacey Liddle about our customer-first approaches and how it has benefitted pharmacies and patients alike.
With the growing demand for pharmacies to take a clinical role, we understand the challenges on time to research the right medication to meet patient need. Idria Dimichele, our resident Medicines Information Pharmacist is on hand to answer your most common questions around unlicensed formulations and offers guidance to help you make the right decisions.
Endorsements of unlicensed medicines should be accurate, concise and legible. Any mistakes could lead to costly and time-consuming errors. We review the most common pitfalls and offer helpful tips and resources to help pharmacists avoid them.
With growing Government pressures on the Healthcare sector to provide 24/7, patient-focused care, we're sensitive to the support required by pharmacies to deliver an efficient morning until night service. Find out how our longer opening hours and rapid turnaround times can support you to meet your customers' needs around the clock.
Effective from 1 December 2015, two lines have been removed from part VIIIB - England and Wales due to a licensed alternative becoming available. Read on to find out more.
Thanks to everyone who took the time to come and see us at the Pharmacy Show in October. It was one of the busiest shows that we remember and we were pleased to be able to catch up with so many of our valued customers over a coffee and frozen yoghurt. If you missed the show, read on to find out what made the top of the showcase agenda this year.
Time is money for busy health care professionals. Sourcing your specials and special obtains from one place is a critical time and money saving initiative that drives operational efficiencies. With our unrivalled range, there should only be one call you need to make. Learn how we help thousands of pharmacies with their requirements all year round through the eyes of our Customer Service Supervisor, Emma Treeby.
Specials Tariffs for England and Wales as well as for Scotland have been updated from 1st November 2015. We have incorporated price and line updates into our processes and paperwork to ensure all customer invoices and endorsements are accurate. Read on for a summary of the changes to both tariffs.
Following on-going shortages of raw materials, we're pleased to confirm we currently have stock availability. Read more to find out about the latest concessionary pricing.
Small stickers are making a big difference to Quantum Pharmaceutical's pharmacy customers. By supplying endorsing information in the form of adhesive labels, Quantum is saving pharmacists valuable time on what is often a laborious process. Pharmacists simply peel off the endorsement, stick it to the prescription, and then submit it for payment.
Part VIII B Specials Tariff now updated!
An array of worthy North East good causes, including the Sir Bobby Robson Foundation, have benefited from a share of £100,000 raised by County Durham's Quantum Pharma Group, as part of its ongoing Corporate Social Responsibility (CSR) programme.
County Durham's Quantum Pharmaceutical has been awarded the Investors in People standard for the second time, demonstrating its ongoing commitment to realising the potential of its staff.
Part VIII B Specials Tariff now updated! From 1st June 2015, 27 lines will be removed from Part VIIIB of the drug tariff; these lines will now be classed as non-tariff specials.
Quantum Pharmaceutical returned to the Sanofi jobs fair at its Fawdon Manufacturing Centre this month, as part of its ongoing quest to recruit the best and brightest from the pharma industry.Back in 2012, Sanofi announced it would cease production at Fawdon by the middle of 2015, with a phased redundancy process in place for almost 250 employees.
The Quantum Pharma team is heading off to London to attend the fourth annual Clinical Pharmacy Congress. Held at London's ExCel between 24-25th April, the Clinical Pharmacy Congress is recognised as the sector's largest and most important event for UK clinical pharmacists, bringing together over 2,000 delegates and 120 exhibitors.
Quantum Pharma Group Commercial Director Brian Fisher took to the stage at the International Numark Conference last month with an engaging presentation about the importance of differentiation for pharmacies, once again demonstrating our ongoing support to our community pharmacy customers.
Emma Evanson of Quantum Pharmaceutical, the UK's leading manufacturer and supplier of unlicensed medicines and special obtain products, attended this year's MediCare Pharmacist Meetings in Belfast and delivered three informative presentations across the city.
The staff at Quantum Pharmaceutical swapped their shirts, ties and lab coats for red noses and fancy dress in an effort to raise funds for this year's Red Nose Day appeal. Quantum Pharmaceutical employs 245 people from all divisions at its Burnopfield headquarters and many of them showed their support by turning up to work in their favourite fancy dress costumes and donning iconic red noses to "do something funny for money".
A North East charity which supports people with Down's Syndrome has been given a boost by Quantum Pharmaceutical, helping it continue its vital work in the area.